Zeria Gets PMS Drug Prefemin Approved In Japan
This article was originally published in PharmAsia News
Executive Summary
Zeria has obtained manufacturing and marketing approval in Japan for its postmenstrual syndrome drug Prefemin.
| Table |
|---|
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SC086832
Ask The Analyst
Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
SC086832
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.